| Vol. 9.45 – 19 November, 2020 |
| |
|
|
| Researchers inhibited endogenous heterotrimeric ENaC channels by introducing inactivating mutant ENaC α mRNA. [Science Advances] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators discovered that scutellarin suppressed inflammation and epithelial–mesenchymal transition in BLM-induced pulmonary fibrosis through NF-κB/NLRP3 signaling. [Cell Death & Disease] |
|
|
|
| Researchers assembled a healthy human lung cell atlas meta-analysis with ~ 130,000 public single-cell transcriptomes and showed that key elements of the bradykinin, angiotensin and coagulation systems were co-expressed with angiotensin converting enzyme-2 (ACE2) in alveolar cells and associated with their differentiation dynamics, which could explain how changes in ACE2 promoted by SARS-CoV-2 cell entry result in the development of the three most severe clinical components of COVID-19. [Scientific Reports] |
|
|
|
| Histological, immunohistochemical, immunofluorescence and molecular analyses, as well as lung function tests, were performed to assess pulmonary emphysema, inflammation and alveolar cell apoptosis. [American Journal of Respiratory Cell and Molecular Biology] |
|
|
|
| Scientists demonstrated that cultured primary bronchial epithelial cells from adults with asthma showed different transcriptional and chromatin responses to rhinovirus infection compared to those without asthma. [Communications Biology] |
| |
|
|
| AMG 757 efficacy was evaluated in small cell lung cancer (SCLC) cell lines and in orthotopic and patient-derived xenograft mouse SCLC models. Following AMG 757 administration, changes in tumor volume, pharmacodynamic changes in tumor-infiltrating T cells (TILs), and the spatial relationship between the appearance of TILs and tumor histology were examined. Tolerability was assessed in nonhuman primates. [Clinical Cancer Research] |
|
|
|
| Scientists assessed lung cancer cell elongation, invasion and migration under treatment with the Smac mimetic LCL161. Functional analyses were performed to detect the contribution of NIK and OTUD7B to LCL161-induced cell invasion and migration. The role of OTUD7B in regulation of the TRAF3/NIK/NF-κB pathway under LCL161 treatment was analysed by immunoblotting, immunoprecipitation, luciferase and ubiquitin assays, shRNA silencing and plasmid overexpression. [Journal of Experimental & Clinical Cancer Research] |
|
|
|
| Based on the analysis of RNA-sequencing data, investigators identified a fusion transcript of CD63–breast cancer anti-oestrogen-resistance 4 (BCAR4) in a Korean patient with lung adenocarcinoma who did not harbour any known activating mutations in EGFR and KRAS genes. To investigate the oncogenic effect of CD63–BCAR4, in vitro and in vivo animal experiments were performed. [British Journal of Cancer] |
|
|
|
| Researchers revealed that the YAP signature, which was highly enriched in mesenchymal‐type lung cancer, was closely correlated to AXL expression in 181 lung cancer cell lines. Moreover, using isogenic lung cancer cell pairs, they also found that doxorubicin treatment induced YAP nuclear translocation in mesenchymal‐type lung cancer cells to induce AXL expression. [Molecular Oncology] |
|
|
|
|
| The authors review the application of CRISPR-Cas in non-small cell lung cancer (NSCLC) for development of mutant models, drug screening, target validation, novel target discoveries, and other emerging potential applications [Cancer Gene Therapy] |
|
|
|
|
| BeiGene, Ltd. announced that the RATIONALE 303 trial of its anti-PD-1 antibody tislelizumab versus docetaxel in the second- or third-line setting in patients with locally advanced or metastatic non-small cell lung cancer who progressed on prior platinum-based chemotherapy, met its primary endpoint of overall survival in the intention-to-treat patient population at the planned interim analysis. [Beigene Ltd.] |
|
|
|
|
| January 9 – January 12, 2021 Lake Buena Vista, Florida, United States |
|
|
|
|
|
| University of North Carolina – Chapel Hill, North Carolina, United States |
|
|
|
| Max Planck Institute for Heart and Lung Research – Bad Nauheim, Germany |
|
|
|
| Fred Hutchinson Cancer Research Center – Seattle, Washington, United States |
|
|
|
| University of Saskatchewan – Saskatoon, Saskatchewan, Canada |
|
|
|
| University of California, San Diego – La Jolla, California, United States |
|
|
|
|